Publication
Role and mechanism of caffeic acid in a mouse model of severe acute pancreatitis
Objective: To investigate the effect and potential mechanism of caffeic acid (CA) on severe acute pancreatitis (SAP) induced by caeru…
What is it about?
This article investigates the protective effects and mechanisms of caffeic acid (CA) in a mouse model of severe acute pancreatitis (SAP) induced by interleukin-1β (IL-1β) and lipopolysaccharide (LPS). The main contents include: by establishing SAP mouse models, observing the effects of CA on pancreatic and lung tissue injury, inflammatory response, and neutrophil-related pathological changes. The results show that CA can significantly alleviate the pathological damage to the pancreas and lung tissues, reduce serum amylase, ALT, AST and other indicators, inhibit the activation of the NF-κB pathway, and reduce the expression of pro-inflammatory factors such as TNF-α, IL-6, and IL-1β. The innovation lies in the first revelation that CA can alleviate systemic inflammation and multi-organ injury associated with SAP by inhibiting neutrophil infiltration and the formation of neutrophil extracellular traps (NETs). The study finds that CA intervention significantly down-regulates the number of MPO-positive cells and CitH3 protein levels, indicating its inhibitory effect on NET formation. In addition, this research expands the application prospects of CA in acute inflammatory diseases and provides experimental evidence for its potential as a therapeutic drug. The results suggest that CA may exert multi-target anti-inflammatory effects by regulating neutrophil function and has the potential for clinical transformation.
Why is it important?
This study explores the therapeutic effects and potential mechanisms of caffeic acid (CA) in a mouse model of severe acute pancreatitis (SAP), which has important scientific and clinical significance. Firstly, CA can significantly alleviate the pathological damage to the pancreas and lung tissues in SAP mice, reduce the levels of serum amylase, lipase, and pro-inflammatory factors (IL-6, TNF-α, etc.), indicating its good anti-inflammatory and organ protective potential. Secondly, the mechanism study shows that CA can inhibit the activation of NF-κB, neutrophil infiltration, and the formation of neutrophil extracellular traps (NETs), revealing its protective effect by regulating innate immune response and providing new ideas for the immunoregulatory treatment of SAP. In addition, although there were no significant changes in colon barrier-related indicators, and there was no obvious damage to liver and kidney function, which may be related to the early observation time point, it still supports the trend of CA's safety. Compared with the existing drug octreotide (OA), CA has a wide source, low cost, and preliminary effects, and has the prospect of being developed as a new auxiliary therapeutic drug. This study provides experimental evidence and theoretical basis for drug intervention in SAP and promotes the exploration of the application of natural compounds in abdominal pain treatment.
